August 28, 2020
Calvin Scott & Company Inc. is recalling a single lot of topiramate because the light-sensitive tablets were repackaged into transparent pouches, according to the August 26, 2020, US Food and Drug Administration (FDA) Enforcement Report.
The recalled 25-mg topiramate tablets (NDC 47335-0707-13) were manufactured by Sun Pharmaceutical Industries, packaged in 10-count bags, and were from lot 19234 (Exp. 9/20). They were distributed by Calvin Scott & Company throughout the United States.
Calvin Scott & Company Inc. initiated the voluntary recall July 27, 2020. The FDA designated the recall Class II on August 20, 2020, signaling use of the product could cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.
Topiramate is a prescription medication used to treat and prevent seizures as well as prevent migraine headaches.